Dr. Bach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-362-1291Fax+1 314-362-4278
Education & Training
- NYU Grossman School of MedicineFellowship, Cardiovascular Disease, 1988 - 1991
- NYU Grossman School of MedicineResidency, Internal Medicine, 1984 - 1987
- New York University School of MedicineClass of 1984
Certifications & Licensure
- MO State Medical License 1991 - 2026
- OH State Medical License 2024 - 2026
- IL State Medical License 1994 - 2023
- NY State Medical License 1986 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2019
- Fellow (FAHA) American Heart Association
- Fellow (FSCAI) Society for Cardiovascular Angiography and Interventions
- Join now to see all
Publications & Presentations
PubMed
- Association between age or duration of diagnosis in obstructive hypertrophic cardiomyopathy and response to mavacamten treatment: Exploratory analysis of the EXPLORER-...Andrew Wang, Neal K Lakdawala, Theodore P Abraham, Ester Kim Nilles, Daniel M Wojdyla
Journal of Cardiac Failure. 2024-12-07 - Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.Suzanne V Arnold, Kensey L Gosch, Chantal Dolan, Jennifer T Fine, Ahmad Masri
Circulation. 2024-11-05 - The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry.Jennifer Rymer, Cayla Pichan, Courtney Page, Brooke Alhanti, Deepak L Bhatt
Journal of Cardiac Failure. 2024-10-01
Press Mentions
- Effect of Simvastatin-Ezetimibe Compared with Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical TrialSeptember 1st, 2019
- Intensive Lipid-Lowering Slashes CVD in Elderly ACS PatientsJuly 19th, 2019
- Vytorin Benefit Greatest in Oldest PatientsJuly 18th, 2019
- Join now to see all
Professional Memberships
- Member
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: